RIAS
PHAT icon

Rachor Investment Advisory Services’s Phathom Pharmaceuticals PHAT Stock Holding History

Rachor Investment Advisory Services’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25
Closed -$278 – 356
2026
Q1 		$278 Hold
25
– – ﹤0.01% 418
2025
Q4 		$415 Buy
+25
New +$357 ﹤0.01% 358

Other funds holding PHAT

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
PMAM
Penn Mutual Asset Management Conshohocken, Pennsylvania $19.5M AUM 3.07% 1-Year Est. Return

Rachor Investment Advisory Services's PHAT Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Phathom Pharmaceuticals (PHAT) in Q2 2026, closing a stake of 25 shares — an estimated $278 sold.

Rachor Investment Advisory Services first reported a position in PHAT in Q4 2025 and held it in 2 quarters. The position peaked at $415 in Q4 2025. 34 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Phathom Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 25 Phathom Pharmaceuticals shares in Q2 2026, an estimated $278.
  • Rachor Investment Advisory Services first reported a position in Phathom Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Phathom Pharmaceuticals position peaked at $415 in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.